International Journal of Clinical Obstetrics and Gynaecology · Mar 2026
Anti-Müllerian hormone as a predictor of ovarian reserve: Correlation with age and BMI
By Tile R, Jamkhandi S
Background: Anti-Müllerian hormone (AMH) is a reliable biomarker of ovarian reserve, reflecting the quantity of remaining ovarian follicles. While age-related decline in AMH is well established, the influence of body mass index (BMI) on AMH levels remains controversial. Objectives: To evaluate serum AMH levels as a predictor of ovarian reserve and to analyze its correlation with age and BMI in reproductive-age women. Materials and Methods: A cross-sectional study was conducted on 100 women aged 20-40 years attending a gynecology outpatient department at ESIC Medical College Kalaburgi. Women with polycystic ovary syndrome, endocrine disorders, prior ovarian surgery, or recent hormonal therapy were excluded. Serum AMH levels were measured using enzyme-linked immunosorbent assay. BMI was calculated and categorized according to WHO criteria. Pearson correlation analysis was used to assess the relationship between AMH, age, and BMI. Results: The mean age of participants was 31.4 ± 5.6 years and the mean BMI was 24.8 ± 3.9 kg/m². Mean serum AMH level was 2.5 ± 1.8 ng/mL. A strong negative correlation was observed between AMH levels and age (r = -0.65; p< 0.001). A moderate inverse correlation was also noted between AMH and BMI (r = -0.32; p = 0.002), with lower AMH levels observed in overweight and obese women compared to those with normal BMI. Conclusion: Serum AMH levels show a significant inverse relationship with age and a moderate negative correlation with BMI, confirming its utility as a predictor of ovarian reserve. Consideration of BMI alongside age may improve clinical interpretation of AMH in fertility assessment.